“The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam” (2013) Clinics, 68(4), pp. 569–573. doi:10.1590/clin.v68i4.76804.